Microbiologics, a biotechnology products and services leader, has chosen Kristen Knox as CEO of the company. An accomplished medical device and life-sciences executive, Knox will assume the role from Brad Goskowicz who served as CEO for 12 years.
During his tenure as CEO of Microbiologics, Goskowicz built an award-winning culture and grew the company’s annual revenues approximately eightfold.
“I have truly enjoyed my time at Microbiologics and working alongside the many wonderful teammates who have become extended family to me," Goskowicz said. "Kristen is an exceptional leader and I am confident the best is yet to come for Microbiologics. I look forward to cheering us on to even greater achievements in the future.”
Goskowicz will continue to support Microbiologics' strategic vision as he transitions to Chairman of the Board of Directors.
Microbiologics has a long history of creating confidence in science for a safer, healthier world. The company’s core values are well-aligned with my personal values and there’s tremendous opportunity to expand their impact throughout the world
- New Microbiologics CEO Kristen Knox
Knox started her career in marketing for healthcare leaders including Mayo Clinic, Ottobock Healthcare and Coloplast. She went on to work for a life-sciences tools company, Data Sciences International, serving in various leadership roles before being appointed to CEO. Most recently, she was Senior VP and General Manager of ACIST Medical Systems, a cardiovascular diagnostic solutions provider.
Knox earned a bachelor’s degree in Marketing from the University of St. Thomas and a master’s degree from Cardinal Stritch University.
“Kristen is an excellent fit as the next CEO of Microbiologics, not only because of her experience and accomplishments in the medical device industry, but also because of her passion for building culture and purpose-driven principles,” said Pat Edeburn, co-founder and operating partner of Microbiologics’ parent company, Granite Partners. “I look forward to seeing where Kristen’s leadership will take Microbiologics.”
“I am deeply inspired and motivated by making a positive impact on human lives, and I strongly believe in the power of science,” added Knox. “Microbiologics has a long history of creating confidence in science for a safer, healthier world. The company’s core values are well-aligned with my personal values and there’s tremendous opportunity to expand their impact throughout the world.”
Microbiologics is a biological products and services provider, specialising in microbiology, molecular diagnostics and virology. They produce retail and custom infectious disease reference materials and provide contract research services for life-science laboratories, manufacturers and suppliers. Microbiologics has multiple BSL-2 and BSL-3 biocontainment facilities and is one of a limited number of commercial BSL-3-cleared laboratories in the United States.
